United States · 
What does Amgen Ventures invest in?
Amgen Ventures invests most often at Series B and Series A (72% of the rounds on record), in sectors such as Biopharma and Therapeutics.
Amgen Ventures highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series B and Series A: 72% of its rounds
- 03
1 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- BiopharmaTherapeutics
- Based in
- San Francisco, United States
- Cold pitches
- Not stated
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
The record
Every round we can evidence, newest first19 appearances
- 2026
1 round
- Oct
- 2020
1 round
- Apr
- 2019
1 round
- Jul
- 2018
1 round
- Nov
- 2015
4 rounds
- Nov
- Jul
- May
- Feb
- 2014
5 rounds
- Nov
- Oct
- Jul
- Jun
- Jan
- 2013
1 round
- Dec
- 2008
1 round
- Jan
- 2007
2 rounds
- Aug
- Mar
- 2005
1 round
- Jul
- 2004
1 round
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Calistoga PharmaceuticalsBought by Gilead Sciences$375MFeb 2011
An exit counts when it came after the firm's first round in the company. From historical deal records.